fda warning bpc-157 2024 panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers A step towards expanded patient
A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT Fast growing peptide business faces crucial week at the FDA STAT An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition
Pay in 4 interest-free payments of $5.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



